Join us and @USSONAR_Rh Monday, October 5th at 8:30 pm ET for a webinar with Dr. Jeffrey Curtis (UAB) to discuss vagus nerve-mediated neuroimmune modulation, a novel therapy treatment for rheumatoid arthritis.
Register today: spm.care/webinar
We were honored to have our national surgical PI @RMarkRichardson present RESET-RA results during the Plenary Session at #AANS25.
Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA.
#TheSetPointAdvantage
Today is #WorldArthritisDay, dedicated to raising awareness about the impact of arthritis in our world.
24% of U.S. adults suffer from arthritis. Advances in care & clinical effectiveness are greatly needed for these patients, and we're committed to pursuing solutions. #WAD2022
We spent our volunteer day helping beautify the @BridgeToHome shelter, build/repair furniture, paint walls & create welcoming, functional spaces for the shelter's residents.
It's these kinds of days where we feel most connected to our mission, our community, and each other.
Last week, the @SetPointMed team came together for a day of community service at @BridgeToHome, a local org helping individuals and families in Santa Clarita Valley move from homelessness to housing. Learn more about their work at btohome.org.
Here's Dr. @RMarkRichardson, nat'l co-PI of the RESET-RA study, sharing the study design, and Dr. Frieda Koopman presenting an update on prior studies about treating #RA with #VNS.
We continue to advance this promising therapy for autoimmune conditions!
#Rheumatology#MedEd
Our Chief Medical Officer David Chernoff will be at CCR-W to discuss the ongoing RESET-RA study. Please stop by poster in the Carousel room on 9/18 to say hello and learn more about the study using vagus nerve stimulation to treat #RA.
#TheSetPointAdvantage#CCRWest#CCR21
In recognition of #PainAwarenessMonth, please join us to raise awareness for how 1.5+ million Americans suffering from #RA and their loved one’s cope with pain every day.
See resources at:
bit.ly/2Wz6KM4bit.ly/3mEZYQf
Our Director of Research, Yaakov Levine PhD will be at CCR-E to discuss the ongoing RESET-RA study. Please stop by poster in Coral B Ballroom on 8/12 to say hello and learn more about the study using vagus nerve stimulation to treat #RA.
#TheSetPointAdvantage#CCREast#CCR21
We are looking forward to discussing SetPoint’s recent developments at the LifeSci Partners Private Company Summer Symposium. CEO Murthy Simhambhatla will present virtually July 22nd from 3:30 – 3:55 pm ET.
#TheSetPointAdvantage#LifeSci#bioelectronicmedicine
With vaccinations and easing of Covid restrictions, the #SetPoint team celebrated the reopening of our offices with a company picnic. It was a blast reconnecting in-person again! Thank you to our dedicated team for their perseverance in developing #bioelectronicmedicine.
#RA affects nearly 1.5 million Americans. Today, we take a moment to bring attention to this chronic disease, and raise awareness for this underserved population.
#TheSetPointAdvantage#RAday
We are excited to present our pilot rheumatoid arthritis study results at the upcoming annual @ACRheum Meeting in Atlanta this weekend!
#ACR19#TheSetPointAdvantage
SetPoint Medical is continuously inspired by @vagusnervegirl's story as we advance our therapy so more patients like Kelly can experience the potential benefits of #BioelectronicMedicine. Read more from the @TIME article here: bit.ly/2WOyF76#TheSetPointAdvantage
SetPoint Medical celebrated the end of a productive summer with a company picnic last week to recognize our stellar employees and their families. To us, diversity and talent are vital for our mission to pioneer bioelectronic medicine.
#WorkHardPlayHard#TheSetPointAdvantage
New research strengthens the understanding of science behind #vagusnerve role in regulating inflammation related to cognitive function after injury & surgery
corporate.dukehealth.org/new…
SetPoint Medical announces Murthy Simhambhatla as new President and CEO. We welcome his extensive healthcare industry leadership as we advance our proprietary #bioelectronicmedicine platform to treat patients with debilitating #autoimmune diseases. setpointmedical.com/setpoint…